Why Canada Needs to Build its Biomanufacturing Capacity

What does it take to build a truly thriving domestic biotech sector? Check out this timely article featuring expert perspectives from Dr. Maura Campbell, President and CEO of OBIO®, on how we can foster a booming life sciences industry together. Learn how OBIO® is actively supporting early-stage and venture-backed life sciences & health tech companies through its programs and collaborations as they navigate the complex road to commercialization.

Previous
Previous

Renewed Momentum for the RNA Sector in Québec with Nearly $11M in Additional Funding for AReNA

Next
Next

Yellowbird Diagnostics Completes Dosing inFirst-in-Human Phase 1 Trial of NeuCaVis™